3D-QSAR modeling of Phosphodiesterase-5 inhibitors: evaluation and comparison of the receptor- and ligand-based alignments
3D-QSAR modeling of Phosphodiesterase-5 inhibitors: evaluation and comparison of the receptor- and ligand-based alignments
复制标题
磷酸二酯酶 5 抑制剂的 3D-QSAR 建模:基于受体和配体的比对的评估和比较
DOI:
10.1007/s00044-019-02311-x
复制
发表时间:
2019-06
影响因子:
2.6
通讯作者:
Cai Xiong
中科院分区:
文献类型:
--
作者:
Jiang Zan;Zheng Xuehua;Li Zhong;Pan Shuqiong;Wang Xiaoyu;Zhang Chen;Li Zhe;Luo Hai Bin;Wu Deyan;Cai Xiong
Phosphodiesterase-5 (PDE5) inhibitors can be used as clinical agents for the treatment of erectile dysfunction and pulmonary hypertension. A series of aryl-chromeno-pyrrol derivatives were previously identified as PDE5 inhibitors in our lab. Herein, these molecules were subjected to 3D-QSAR analysis with CoMFA and CoMSIA methods to gain deeper insight into the structural requirements for their bioactivities. Receptor- and ligand-based alignment were used and compared to find the alignment-related factors that affect the accuracy of QSAR models. The receptor-based CoMFA and CoMSIA models, which were generated by superimposing the docking conformations directly in the protein binding site, gave more significant results for 38 training set compounds and 5 test set molecules. Comparison of the two alignments revealed that spatial arrangement of the ligands is the principal factor in determining the reliability of the 3D-QSAR models. Detailed analysis of the receptor-based CoMSIA-SE contour maps provided much helpful information to improve the bioactivities of aryl-chromeno-pyrrol analogs as PDE5 inhibitors.
登录
查看更多内容
影响因子:
6.7
作者:
T. Oh;K. Kang;B. Ahn;M. Yoo;W. Kim
通讯作者:
T. Oh;K. Kang;B. Ahn;M. Yoo;W. Kim
影响因子:
2.8
作者:
H. Porst
通讯作者:
H. Porst
影响因子:
4.3
作者:
Dioma U. Udeoji;E. Schwarz
通讯作者:
Dioma U. Udeoji;E. Schwarz
影响因子:
2.7
作者:
Xuehua Zheng;Yinuo Wu;Deyan Wu;Xinhua Wang;Chao Zhang;Xiaolei Guo;Hai-Bin Luo
通讯作者:
Hai-Bin Luo
影响因子:
158.5
作者:
Galiè, N;Ghofrani, HA;Simonneau, G
通讯作者:
Simonneau, G